These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Ago Y, Kawasaki T, Nashida T, Ota Y, Cong Y, Kitamoto M, Takahashi T, Takuma K, Matsuda T. Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118 [Abstract] [Full Text] [Related]
14. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain. Cao L, Li D, Feng P, Li L, Xue GF, Li G, Hölscher C. Neuroreport; 2016 Apr 13; 27(6):384-91. PubMed ID: 26918675 [Abstract] [Full Text] [Related]
15. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease. Zhang L, Huang L, Chen L, Hao D, Chen J. Toxicol Lett; 2013 Oct 24; 222(2):155-63. PubMed ID: 23911879 [Abstract] [Full Text] [Related]
20. Physical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner. Klaissle P, Lesemann A, Huehnchen P, Hermann A, Storch A, Steiner B. BMC Neurosci; 2012 Oct 31; 13():132. PubMed ID: 23110504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]